PROlectin M, a Nucleocapsid TErminal GaleCTin Antagonist for COVID-19
Conditions: COVID-19; COVID-19 Pandemic; COVID-19 Respiratory Infection; SARS-CoV2 Infection; Cytokine Release Syndrome Interventions: Drug: Galactomannan; Drug: PLACEBO Sponsors: Pharmalectin Inc; ALKE RESEARCH PRIVATE LIMITED; Research Consultancy Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - October 27, 2021 Category: Research Source Type: clinical trials
PROlectin M, a Nucleocapsid TErminal GaleCTin Antagonist for COVID-19
Conditions: COVID-19; COVID-19 Pandemic; COVID-19 Respiratory Infection; SARS-CoV2 Infection; Cytokine Release Syndrome Interventions: Drug: Galactomannan; Drug: PLACEBO Sponsors: Bioxytran Inc.; ALKE RESEARCH PRIVATE LIMITED; Research Consultancy Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - October 27, 2021 Category: Research Source Type: clinical trials
Rheumatoid Arthritis, Planned Behav ıor Theory And Nurse Counselıng
Condition: Rheumatoid Arthritis Intervention: Behavioral: TRAINING AND CONSULTANCY Sponsor: Hasan Kalyoncu University Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - September 9, 2021 Category: Research Source Type: clinical trials